Maintenance Therapy in Dehradun
Maintenance Therapy in Dehradun
Maintenance therapy is a treatment approach used after the initial cancer treatment such as surgery and chemotherapy to help prevent cancer from returning. The goal of maintenance therapy is to keep the cancer under control and prolong the period during which the disease remains in remission.
In gynecologic oncology, maintenance therapy is commonly used for patients with ovarian cancer and certain other gynecologic cancers after successful completion of primary treatment.
When May a Patient Need Maintenance Therapy?
Maintenance therapy may be considered when a patient has completed the initial treatment phase and the cancer has responded or is under control.
After a Response to Chemotherapy
Some patients may be considered for continued treatment after responding to their initial chemotherapy.
In Selected Ovarian Cancers
Maintenance treatment may be recommended for certain ovarian cancer patients based on their disease characteristics, previous treatment response and biomarker or genetic test results.
When Targeted Treatment Is Appropriate
Some patients may benefit from targeted medicines when their tumour characteristics and clinical history support their use.
When Ongoing Disease Control Is Needed
For selected cancers, continued treatment may be considered to help delay disease progression and maintain the response achieved.
Potential Benefits of Maintenance Therapy
Frequently Asked Questions About Maintenance Therapy
No. Maintenance therapy describes the purpose and phase of treatment, not one specific medicine. It may involve targeted therapy, hormonal therapy or other medicines. Some maintenance treatments may also use chemotherapy, depending on the cancer and clinical situation.
Eligibility depends on the cancer type, stage, response to initial treatment, previous medicines, biomarker or genetic test results and overall health.
Yes. It is an established treatment approach in selected ovarian cancer cases. Options may include PARP inhibitors or bevacizumab, depending on the patient's clinical profile and treatment history.
Side effects depend on the medicine being used. They may include fatigue, nausea, changes in blood counts, blood pressure changes or other medicine-specific effects. Patients should discuss possible side effects with their oncologist.
Patients should not stop or change prescribed treatment without consulting their oncologist. The decision depends on treatment goals, duration, response and side effects.